Document Detail


Stimulation of oxygen consumption of platelets by Solcoseryl and cardiocrome during in vitro aging for 5 days.
MedLine Citation:
PMID:  2170724     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Solcoseryl (SOL) and Cardiocrome (CAR) produced decreases in the partial oxygen pressure of platelet suspensions, indicating the acceleration of platelet oxygen consumption. However, the peak response to CAR was much faster than that to SOL. Application of 1 ml of SOL to 20 ml of platelet suspension stored for 1 day produced increases of 1 nmol ATP per min per 10(9) platelets. The same increases in oxygen consumption appeared after 3 or 5 day-storage.
Authors:
T Shimizu
Related Documents :
11761274 - The evaluation of microbial contamination in platelet concentrates prepared by two diff...
3114954 - Studies on the procurement of blood coagulation factor viii in vitro studies on blood c...
3475954 - Effect of flavonoid on pge2-induced alterations in percentage collagen synthesis in oss...
24735964 - Sdf-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady-s...
11576934 - Platelet aggregation and prostaglandin metabolism in uremic patients.
2431974 - Relationship between erythrocyte volume and count after experimental induction of anaem...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article    
Journal Detail:
Title:  Japanese journal of pharmacology     Volume:  53     ISSN:  0021-5198     ISO Abbreviation:  Jpn. J. Pharmacol.     Publication Date:  1990 Aug 
Date Detail:
Created Date:  1990-11-19     Completed Date:  1990-11-19     Revised Date:  2010-07-20    
Medline Journal Info:
Nlm Unique ID:  2983305R     Medline TA:  Jpn J Pharmacol     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  499-501     Citation Subset:  IM    
Affiliation:
Research Division, Aichi Center, Japanese Red Cross Blood Transfusion Service, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Actihaemyl / pharmacology*
Blood Platelets / metabolism*
Cytochrome c Group / pharmacology*
Cytochromes c*
Drug Combinations
Flavin Mononucleotide / pharmacology*
Humans
Oxygen Consumption / drug effects*
Stimulation, Chemical
Thiamine Pyrophosphate / pharmacology*
Time Factors
Chemical
Reg. No./Substance:
0/Cytochrome c Group; 0/Drug Combinations; 0/cytochrome C, flavin mononucleotide, thiamine pyrophosphate drug combination; 146-17-8/Flavin Mononucleotide; 154-87-0/Thiamine Pyrophosphate; 37239-28-4/Actihaemyl; 9007-43-6/Cytochromes c

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psych...
Next Document:  Increases in alpha-but not beta-adrenoceptors in hypertrophied non-infarcted cardiac muscles from ra...